相关实验视频
Updated: Jun 3, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.1K
由SLC27A2缺乏引起的长链脂肪酸再分配促进肝细胞癌的低毒性适应和免疫抑制
Chuli Fu1, Wenyun Fu2, Zuotian Huang3
1Guangzhou Medical University, China.
Cancer research
|September 3, 2025
概括
在肝细胞癌 (HCC) 中,低SLC27A2表达通过改变脂肪酸代谢来促进瘤存活和治疗耐药性. 这突出了HCC治疗的新治疗目标.
科学领域:
- 癌症学
- 癌症新陈代谢
- 分子生物学
背景情况:
- 肝细胞癌 (HCC) 的特征是缺氧,免疫逃避和代谢重编程,这阻碍了治疗的有效性.
- 溶液载体 (SLC) 家族成员对于在低氧压力下维持瘤细胞平衡至关重要.
- 了解SLC家族在HCC低氧微环境中的作用可能会揭示新的治疗策略.
研究的目的:
- 在肝细胞癌中研究溶解物载体家族27成员2 (SLC27A2) 的作用.
- 确定SLC27A2降低对瘤行为和治疗反应的影响.
- 阐明SLC27A2在HCC进展中的作用的代谢机制.
主要方法:
- 在HCC患者群体中SLC27A2表达的生物信息分析.
- 使用不同SLC27A2表达水平的HCC细胞系进行了体外实验.
- 低氧耐受性,治疗耐药性和代谢特征 (长链脂肪酸摄取,脂质过氧化) 的评估.
- 研究HCC细胞与瘤相关巨细胞 (TAMs) 之间的相互作用.
主要成果:
- 在HCC中,SLC27A2经常下调,与瘤攻击性增加和不良结果相关.
- 降低SLC27A2表达增强了HCC细胞对缺氧的耐受性和对跨动脉化学栓塞 (TACE) 和抗血管原剂等治疗的耐药性.
- 降低SLC27A2抑制长链脂肪酸 (LCFA) 摄取,防止低氧化时的脂质过氧化和相关细胞毒性.
- 缺乏SLC27A2的HCC细胞对谷氨酸酶和脂肪酸合成酶抑制剂表现出敏感性.
- 通过PPAR-γ激活和SPP1+TAM丰富,促进免疫抑制,但为抗PD-1治疗创造了一个机会.
结论:
- 通过改变LCFA代谢和促进瘤进展,降低HCC细胞中SLC27A2的调节促进了低氧应激的适应.
- 由低SLC27A2驱动的LCFA在癌细胞和TAM之间重新分配有助于免疫抑制,并呈现出治疗脆弱性.
- 针对LCFA代谢和免疫检查点为HCC治疗提供了有前途的途径.
相关概念视频
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...